πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors β€” phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β€” searchable for business development and competitive intelligence.

7,387 results for β€œLe” Clear

  1. Vabysmo 120 mg/mL solution for injection in pre-filled syringe

    The George Institute

    SUBRETINAL HYPERREFLECTIVE MATERIAL

    approved small molecule active

    1 trial
  2. Valbenazine Oral Capsule

    NEUROCRINE BIOSCIENCES INC

    Tardive Dyskinesia

    approved small molecule terminated

    1 trial
  3. Valproic acid

    Hospital Authority, Hong Kong

    Drug Resistant Epilepsy

    approved small molecule active

    1 trial
  4. Vancomycin

    The First People's Hospital of Lianyungang

    Blood Stream Infections

    approved small molecule active

    1 trial
  5. Vardenafil

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Erectile Dysfunction

    approved small molecule active

    1 trial
  6. Vaxigrip Tetra, suspensie voor injectie in een voorgevulde spuit Quadrivalent griepvaccin (gesplitst virion, geΓ―nactiveerd), Fluenz Tetra nasal spray suspension Influenza vaccine (live attenuated, nasal)

    Disc Medicine

    healthy individuals

    approved small molecule active

    1 trial
  7. Venetoclax

    AbbVie

    Acute Myeloid Leukemia (AML)

    approved small molecule active

    1 trial
  8. Vifor

    The First People's Hospital of Lianyungang

    Malnutrition

    approved small molecule completed

    1 trial
  9. Vitamine E-400 complex, Microgynon 30, 0,15 mg/0,03 mg omhulde tabletten

    Disc Medicine

    Migraine

    approved small molecule active

    1 trial
  10. Voltaren SPORT, 11,6 mg/g, ΕΌel, Voltaren MAX, 23,2 mg/g, ΕΌel

    HALEON AUSTRALIA PTY LTD

    Mild/non-serious osteoarthritis (OA) of the knee.

    approved small molecule active

    1 trial
  11. Vonoprazan

    The First People's Hospital of Lianyungang

    Helicobacter Pylori Infection

    approved small molecule active

    2 trials
  12. Vonoprazan

    The First People's Hospital of Lianyungang

    Ulcers, Gastric

    approved small molecule active

    1 trial
  13. Vonoprazan and Amoxicillin for the first 7 days

    The First People's Hospital of Lianyungang

    Helicobacter Pylori Infection

    approved small molecule active

    1 trial
  14. Vyndaqel 61 mg soft capsules

    Monte Rosa Therapeutics

    Transthyretin cardiac amyloidosis

    approved small molecule active

    1 trial
  15. WARFARIN, LYSINE ASPIRIN, CLOPIDOGREL, ACETYLSALICYLIC ACID, ATORVASTATIN, DILTIAZEM, BISOPROLOL, ACETYLCHOLINE CHLORIDE, GLYCERYL TRINITRATE, RAMIPRIL

    Fondazione Telethon ETS

    Myocardial infarction with non-obstructive coronary arteries (MINOCA)

    approved small molecule active

    1 trial
  16. Wangbi granules

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Rheumatoid Arthritis

    approved small molecule active

    1 trial
  17. Wegovy 0.25 mg FlexTouch solution for injection in pre-filled pen, Wegovy 1 mg FlexTouch solution for injection in pre-filled pen, Wegovy 0.5 mg FlexTouch solution for injection in pre-filled pen, Wegovy 2.4 mg FlexTouch solution for injection in pre-filled pen, Wegovy 1.7 mg FlexTouch solution for injection in pre-filled pen

    NovoThirteen

    Obesity

    approved small molecule active

    1 trial
  18. Wegovy 0.5 mg FlexTouch solution for injection in pre-filled pen, Wegovy 1.7 mg FlexTouch solution for injection in pre-filled pen, Wegovy 2.4 mg FlexTouch solution for injection in pre-filled pen, Wegovy 0.25 mg FlexTouch solution for injection in pre-filled pen, Wegovy 1 mg FlexTouch solution for injection in pre-filled pen

    Lacuna Pharma Pty Ltd

    Adipositas

    approved small molecule active

    1 trial
  19. Wegovy 2.4 mg solution for injection in pre-filled pen

    The George Institute

    obstructive sleep apnea

    approved small molecule active

    1 trial
  20. Wen Xin granule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Coronary Heart Disease

    approved small molecule active

    1 trial
  21. XALKORI 200 mg hard capsules, XALKORI 250 mg hard capsules, Crizotinib 200 mg capsules, Crizotinib 250 mg capsules

    Pfizer Australia Pty Ltd

    This Master Protocol for Crizotinib Continuation Sub-Studies has been designed to provide continued treatment access for eligible participants who continue to derive clinical benefit from study intervention in a Pfizer sponsored crizotinib parent study that will be closed

    approved small molecule active

    1 trial
  22. XELJANZ 11 mg prolonged-release tablets

    Disc Medicine

    Rheumatoid arthritis or psoriatic arthritis according to respectively 2010 criteria or CASPAR criteria

    approved small molecule active

    1 trial
  23. Xingnaojing injection

    The First People's Hospital of Lianyungang

    Ischemic Stroke, Acute

    approved small molecule active

    1 trial
  24. Xinnaoning Capsule

    BRIGHT MINDS BIOSCIENCES INC.

    Chronic Stable Angina Pectoris

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β€” verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources